New research at ACR Convergence 2023, the American College of Rheumatology’s annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining a robust response to vaccines.
Marks rehashes Covid-19 approval timeline, defends vaccines for children at hearing
FDA’s Peter Marks appeared before a House panel on Thursday to field questions on how to improve the nation’s vaccine safety systems in the event